Asthma Inhaler Switch Coming in January

Doctors are warning asthma patients about a big change coming to inhalers.

Doctors are warning asthma patients about a big change coming to inhalers. Starting monday, the asthma inhaler ‘Flovent,’ made by GSK, will disappear from pharmacy shelves. Physicians says an authorized generic version, to take its place, will work just as well, however it doesn’t appear to be covered as widely by insurers. Doctors are urging patients to take action now to get new prescriptions if needed and sort out coverage issues, especially during respiratory virus season. Industry insiders say GSK is discontinuing ‘Flovent’ due to medicaid rebate changes that would force the company to pay large penalties for hiking prices.